Cancer and Metastasis Reviews

, Volume 14, Issue 2, pp 91–95 | Cite as

Assessing new anti-tumour agents and strategies in oncogene transgenic mice

  • Hilary Thomas
  • Frances Balkwill

Key words

oncogene transgenic experimental therapeutics cytokine screening 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Collins JM, Grieshaber CK, Chabner BA: Pharmacologically guided phase I clinical trials based on preclinical drug development. J Natl Cancer Inst 82: 1321–1326, 1990Google Scholar
  2. 2.
    Fidler IJ: Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastases. Cancer and Metastasis Reviews 5: 29–49, 1986Google Scholar
  3. 3.
    Jenkins NA, Copeland NG: Transgenic mice in cancer research. Important Adv Oncol: 61-77, 1989Google Scholar
  4. 4.
    Adams JM, Croy S: Transgenic models of tumour development. Science 254: 1161–1167, 1991Google Scholar
  5. 5.
    Curt GA: The use of animal models in cancer drug discovery and development. Stem Cells 12: 23–29, 1994Google Scholar
  6. 6.
    De Wille JW, Waddell K, Steinmeyer C, Farmer SJ: Dietary fat promotes mammary tumorigenesis in MMTV/Ha-ras transgenic mice. Cancer Lett 69: 59–66, 1993Google Scholar
  7. 7.
    Iritani N, Nishimoto N, Katsurada A, Fukuda H: Regulation of hepatic lipogenic enzyme gene expression by diet quantity in rats fed a fat-free high carbohydrate diet. J Nutr 122: 28–36, 1992Google Scholar
  8. 8.
    Mahley RW: Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240: 622–630, 1990Google Scholar
  9. 9.
    Strobl W, Gorder NL, Fienup GA, Lin-Lee YC, Gotto AM, Patsch W: Effect of sucrose diet on apolipoprotein biosynthesis in rat liver. Increase in apolipoprotein E gene transcription. J Biol Chem 264: 1190–1194, 1989Google Scholar
  10. 10.
    Hu J, Kindsvogel W, Busby S, Bailey MC, Shi Y-Y, Greenberg PD: An evaluation of the potential to use tumour-associated antigens as targets for antitumour T cell therapy using transgenic mice expressing a retroviral tumour antigen in normal lymphoid tissues. J Exp Med 177: 1681–1690, 1993Google Scholar
  11. 11.
    Nielsen LL, Gurnani M, Tyler RD: Evaluation of the wapras transgenic mouse as a model system for testing anticancer drugs. Cancer Research 52: 3733–3738, 1992Google Scholar
  12. 12.
    Dexter DL, Diamond M, Creveling J, Chen S-F: Chemotherapy of mammary carcinomas arising in ras transgenic mice. Investigational New Drugs 11: 161–168, 1993Google Scholar
  13. 13.
    Yukawa K, Kikutani H, Inomoto T, Uehira M, Bin SH, Akagi K, Yamamura K, Kishimoto T: Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (Eµ)-myc transgenic mice. J Exp Med 170: 711–726, 1989Google Scholar
  14. 14.
    Cho HJ, Seiberg M, Georgoff I, Teresky AK, Marks JR, Levine AJ: Impact of genetic background of transgenic mice upon the formation and timing of choroid plexus papillomas. Journal of Neuroscience Research 24: 115–122, 1989Google Scholar
  15. 15.
    Fox JL: Transgenic mice fall far short. Biotechnology 11: 663, 1993Google Scholar
  16. 16.
    Bouchard L, Lamarre L, Tremblay PJ, Jolicoeur P: Stochastic appearance of mammary tumours in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57: 931–936, 1989Google Scholar
  17. 17.
    Suda Y, Aizawa S, Furuta Y, Yagi Tet al.: Induction of a variety of tumours by c-erb B2 and clonal nature of lymphomas even with the mutated gene (Val659-Glu 659). EMBO J 9: 181–190, 1990Google Scholar
  18. 18.
    Mattern J, Bak M, Haln EW, Manfred V: Human tumour xenografts as model for drug testing. Cancer Metastasis Rev 7: 263–284, 1988Google Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Hilary Thomas
    • 1
  • Frances Balkwill
    • 1
  1. 1.Imperial Cancer Research FundLincoln's Inn FieldsLondonUK

Personalised recommendations